US Patent Issued to POLARIS PHARMACEUTICALS. on Nov. 25 for "Methods and kits for identifying subjects responsive to arginine deprivation therapy" (Taiwanese Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,685, issued on Nov. 25, was assigned to POLARIS PHARMACEUTICALS. INC. (San Diego).

"Methods and kits for identifying subjects responsive to arginine deprivation therapy" was invented by Hung-Wen Chen (Taipei, Taiwan), Hui-Fen Liu (Taipei, Taiwan), Chau-Ting Yeh (Taoyuan, Taiwan), Yu-De Chu (Taoyuan, Taiwan) and Chun-Hung Chou (Taipei, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods and kits for identifying responsiveness or non-responsiveness of a cancer subject to arginine deprivation therapy. The method includes determining the presence of a G/G genotype of rs13338697 of the target nucleic acid in a biological sa...